Cargando…
What should be the core outcomes in chronic pain clinical trials?
A consensus conference with representatives from academia, governmental agencies, and the pharmaceutical industry met and concluded that clinical trials designed to assess the efficacy and effectiveness of treatments for chronic pain should consider outcomes in six core domains: pain, physical funct...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC464897/ https://www.ncbi.nlm.nih.gov/pubmed/15225358 http://dx.doi.org/10.1186/ar1196 |
_version_ | 1782121610936844288 |
---|---|
author | Turk, Dennis C Dworkin, Robert H |
author_facet | Turk, Dennis C Dworkin, Robert H |
author_sort | Turk, Dennis C |
collection | PubMed |
description | A consensus conference with representatives from academia, governmental agencies, and the pharmaceutical industry met and concluded that clinical trials designed to assess the efficacy and effectiveness of treatments for chronic pain should consider outcomes in six core domains: pain, physical functioning, emotional functioning, patient global ratings of satisfaction, negative health states and adverse events, and patient disposition. In addition, it was acknowledged that there are many secondary domains that might be of importance and should be included in trials depending on the nature of the treatment and population to whom the treatment is targeted. |
format | Text |
id | pubmed-464897 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-4648972004-07-16 What should be the core outcomes in chronic pain clinical trials? Turk, Dennis C Dworkin, Robert H Arthritis Res Ther Commentary A consensus conference with representatives from academia, governmental agencies, and the pharmaceutical industry met and concluded that clinical trials designed to assess the efficacy and effectiveness of treatments for chronic pain should consider outcomes in six core domains: pain, physical functioning, emotional functioning, patient global ratings of satisfaction, negative health states and adverse events, and patient disposition. In addition, it was acknowledged that there are many secondary domains that might be of importance and should be included in trials depending on the nature of the treatment and population to whom the treatment is targeted. BioMed Central 2004 2004-06-04 /pmc/articles/PMC464897/ /pubmed/15225358 http://dx.doi.org/10.1186/ar1196 Text en Copyright © 2004 BioMed Central Ltd |
spellingShingle | Commentary Turk, Dennis C Dworkin, Robert H What should be the core outcomes in chronic pain clinical trials? |
title | What should be the core outcomes in chronic pain clinical trials? |
title_full | What should be the core outcomes in chronic pain clinical trials? |
title_fullStr | What should be the core outcomes in chronic pain clinical trials? |
title_full_unstemmed | What should be the core outcomes in chronic pain clinical trials? |
title_short | What should be the core outcomes in chronic pain clinical trials? |
title_sort | what should be the core outcomes in chronic pain clinical trials? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC464897/ https://www.ncbi.nlm.nih.gov/pubmed/15225358 http://dx.doi.org/10.1186/ar1196 |
work_keys_str_mv | AT turkdennisc whatshouldbethecoreoutcomesinchronicpainclinicaltrials AT dworkinroberth whatshouldbethecoreoutcomesinchronicpainclinicaltrials |